
About
Christina Kuhn provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.

5 Digital Health Issues to Watch at FDA in 2022
FDA Releases AI Action Plan
FDA Issues Final Guidance on Multiple Function Digital Health Software and Other Devices

AI/IoT Update: The Potential Benefits of Digital Health Technology in Managing COVID-19
COVID-19: FDA Regulatory Considerations for Digital Health Solutions
FDA Issues Updated Guidance on the Regulation of Digital Health Technologies
Top 10 Questions During Ideation of Digital Health Solutions
Significant FDA Digital Health Policy Development for Prescription Drug Sponsors
Inside FDA’s Latest Digital Health Developments: Gottlieb Sees “Vast Potential” Ahead
About
Christina Kuhn provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.